Literature DB >> 16160157

Impact of the placental cytokine-chemokine balance on regulation of cell-cell contact-induced human immunodeficiency virus type 1 translocation across a trophoblastic barrier in vitro.

Muriel Derrien1, Albert Faye, Guillermina Dolcini, Gérard Chaouat, Françoise Barré-Sinoussi, Elisabeth Menu.   

Abstract

Cells constituting the placental barrier secrete soluble factors that may participate in controlling human immunodeficiency virus type 1 (HIV-1) transmission from the mother to the fetus. In this study, we asked whether placental soluble factors (PSF) could limit cell-cell contact inducing HIV-1 production that occurs after inoculation of HIV-1-infected peripheral blood mononuclear cells (HIV-1+ PBMCs) onto trophoblast-derived BeWo cells grown as tight and polarized barriers in a two-chamber system. The activity of recombinant chemokines and cytokines expressed by placental tissue and of factors secreted by either early or term placentae of HIV-1-negative women, was analyzed. We identified chemokines (RANTES and MIP-1beta) and cytokines (tumor necrosis factor alpha and interleukin-8) that decreased and increased, respectively, viral production in trophoblast barrier cells inoculated with HIV-1+ PBMCs. Unexpectedly, factors secreted by either early or term placentae of HIV-1-negative women enhanced viral production. Nevertheless, the same PSF did not favor infection of trophoblastic barriers with cell-free HIV-1 and strongly reduced viral production in PBMCs infected with cell-free HIV-1. Moreover, PSF contained chemokines (RANTES and MIP-1beta) and a cytokine, leukemia inhibitory factor, exhibiting a strong anti-HIV-1 activity in our model of cell-to-cell infection. Together these data suggested that at the maternal interface the global activity of PSF is related to the synergistic action of several soluble factors with a balance in favor of an enhancing activity on the passage of viruses across the trophoblast barrier. This could explain the presence of viral sequences in trophoblasts in all placentae of HIV-1-infected women.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16160157      PMCID: PMC1211513          DOI: 10.1128/JVI.79.19.12304-12310.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  SDF-1 production by placental cells: a potential mechanism of inhibition of mother-to-fetus HIV transmission.

Authors:  A Coulomb-L'Hermine; D Emilie; I Durand-Gasselin; P Galanaud; G Chaouat
Journal:  AIDS Res Hum Retroviruses       Date:  2000-07-20       Impact factor: 2.205

Review 2.  A brief review of recent data on some cytokine expressions at the materno-foetal interface which might challenge the classical Th1/Th2 dichotomy.

Authors:  Gérard Chaouat; Sandrine Zourbas; Sasa Ostojic; Geneviève Lappree-Delage; Sylvie Dubanchet; Natalie Ledee; Jacques Martal
Journal:  J Reprod Immunol       Date:  2002-01       Impact factor: 4.054

Review 3.  Extinguishing maternal immune responses during pregnancy: implications for immunosuppression.

Authors:  A L Mellor; D H Munn
Journal:  Semin Immunol       Date:  2001-08       Impact factor: 11.130

4.  Cell-to-cell contact results in a selective translocation of maternal human immunodeficiency virus type 1 quasispecies across a trophoblastic barrier by both transcytosis and infection.

Authors:  S Lagaye; M Derrien; E Menu; C Coïto; E Tresoldi; P Mauclère; G Scarlatti; G Chaouat; F Barré-Sinoussi; M Bomsel
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  Up-regulation of CCR5 expression in the placenta is associated with human immunodeficiency virus-1 vertical transmission.

Authors:  H Behbahani; E Popek; P Garcia; J Andersson; A L Spetz; A Landay; Z Flener; B K Patterson
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

6.  Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy.

Authors:  B R Lane; K Lore; P J Bock; J Andersson; M J Coffey; R M Strieter; D M Markovitz
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

7.  Placental cytokine and chemokine production in HIV-1-infected women: trophoblast cells show a different pattern compared to cells from HIV-negative women.

Authors:  M Moussa; P Roques; N Fievet; E Menu; J G Maldonado-Estrada; J Brunerie; R Frydman; X Fritel; F Herve; G Chaouat
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

8.  Evaluation of the placental environment with a new in vitro model of histocultures of early and term placentae: determination of cytokine and chemokine expression profiles.

Authors:  A Faye; S Pornprasert; G Dolcini; P Ave; J Taïeb; J L Taupin; M Derrien; M Huerre; F Barré-Sinoussi; G Chaouat; E Menu
Journal:  Placenta       Date:  2005 Feb-Mar       Impact factor: 3.481

9.  Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women.

Authors:  B K Patterson; H Behbahani; W J Kabat; Y Sullivan; M R O'Gorman; A Landay; Z Flener; N Khan; R Yogev; J Andersson
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

10.  Production of interferons and beta-chemokines by placental trophoblasts of HIV-1-infected women.

Authors:  B N Lee; H Hammill; E J Popek; S Cron; C Kozinetz; M Paul; W T Shearer; J M Reuben
Journal:  Infect Dis Obstet Gynecol       Date:  2001
View more
  10 in total

1.  Elevated cytokine and chemokine levels in the placenta are associated with in-utero HIV-1 mother-to-child transmission.

Authors:  Surender B Kumar; Cara E Rice; Danny A Milner; Nilsa C Ramirez; William E Ackerman; Victor Mwapasa; Abigail Norris Turner; Jesse J Kwiek
Journal:  AIDS       Date:  2012-03-27       Impact factor: 4.177

2.  Maternal obesity, diabetes mellitus and cord blood biomarkers in large-for-gestational age infants.

Authors:  Karen Mestan; Fengxiu Ouyang; Nana Matoba; Colleen Pearson; Katherin Ortiz; Xiaobin Wang
Journal:  J Pediatr Biochem       Date:  2010-01-01

3.  Insights Into Circulating Cytokine Dynamics During Pregnancy in HIV-Infected Beninese Exposed to Plasmodium falciparum Malaria.

Authors:  Samad A Ibitokou; Lise Denoeud-Ndam; Sèm Ezinmegnon; Rodolphe Ladékpo; Djimon-Marcel Zannou; Achille Massougbodji; Pierre-Marie Girard; Michel Cot; Adrian J F Luty; Nicaise Tuikue Ndam
Journal:  Am J Trop Med Hyg       Date:  2015-06-22       Impact factor: 2.345

4.  Characterization of the main placental cytokine profiles from HIV-1-infected pregnant women treated with anti-retroviral drugs in France.

Authors:  A Faye; S Pornprasert; J-Y Mary; G Dolcini; M Derrien; F Barré-Sinoussi; G Chaouat; E Menu
Journal:  Clin Exp Immunol       Date:  2007-05-18       Impact factor: 4.330

5.  Decidual soluble factors participate in the control of HIV-1 infection at the maternofetal interface.

Authors:  Romain Marlin; Marie-Thérèse Nugeyre; Marion Duriez; Claude Cannou; Anne Le Breton; Nadia Berkane; Françoise Barré-Sinoussi; Elisabeth Menu
Journal:  Retrovirology       Date:  2011-07-18       Impact factor: 4.602

6.  Proteasome-independent degradation of HIV-1 in naturally non-permissive human placental trophoblast cells.

Authors:  Anna Laura Ross; Claude Cannou; Françoise Barré-Sinoussi; Elisabeth Menu
Journal:  Retrovirology       Date:  2009-05-15       Impact factor: 4.602

7.  Tumour necrosis factor-alpha stimulates HIV-1 replication in single-cycle infection of human term placental villi fragments in a time, viral dose and envelope dependent manner.

Authors:  Anfumbom K W Kfutwah; Jean-Yves Mary; Marie-Anne Nicola; Sandra Blaise-Boisseau; Françoise Barré-Sinoussi; Ahidjo Ayouba; Elisabeth Menu
Journal:  Retrovirology       Date:  2006-06-23       Impact factor: 4.602

8.  HIV-1 Nef breaches placental barrier in rat model.

Authors:  Poonam Singh; Saurabh Kumar Agnihotri; Mahesh Chandra Tewari; Sadan Kumar; Monika Sachdev; Raj Kamal Tripathi
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

9.  Antigen-presenting cells represent targets for R5 HIV-1 infection in the first trimester pregnancy uterine mucosa.

Authors:  Romain Marlin; Marie-Thérèse Nugeyre; Claire de Truchis; Nadia Berkane; Amélie Gervaise; Françoise Barré-Sinoussi; Elisabeth Menu
Journal:  PLoS One       Date:  2009-06-22       Impact factor: 3.240

10.  Distinct efficacy of HIV-1 entry inhibitors to prevent cell-to-cell transfer of R5 and X4 viruses across a human placental trophoblast barrier in a reconstitution model in vitro.

Authors:  Ahidjo Ayouba; Claude Cannou; Marie-Thérèse Nugeyre; Françoise Barré-Sinoussi; Elisabeth Menu
Journal:  Retrovirology       Date:  2008-03-31       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.